TAKE Solutions Limited (TAKE) Fair Value & Analysis
Healthcare · IN · Market cap ₹3.3B
Fair value as of: Jul 3, 2026
From 10 valuation models · updated today
Share price −20.2% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹9.00 – ₹50.14 · fair‑value band ₹6.59 – ₹15.77 · the ₹23.97 price screens above the ₹11.14 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
TAKE Solutions Limited (TAKE) currently trades at ₹23.97, while our model-based Fair Value estimate is ₹11.14 — implying the stock looks roughly 53.5% overvalued today. We read business quality at 61/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, TAKE Solutions Limited generated revenue of ₹542M at a net margin of 20.0%. Revenue declined 82.9% year over year. It earns a return on equity of 16.5%. The balance sheet holds a net cash position of ₹2.8M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personalized medicine, wellness, and patient engagement; and medical device solution, such as technological transformation with chip level programming, DICOM devices, wearables, PROM, nano devices, and miOTs. TAKE Solutions Limited was incorporated in 2000 and is based in Chennai, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
TAKE Solutions Limited reported revenue of ₹542M in FY2026 versus ₹6.5B in FY2022, a compound −46.3%/yr. Reported net income was ₹108M in FY2026.
Is TAKE fairly valued? → Check now
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $172.61 | $104.16 | -40% |
| Pro Medicus Limited PME | A$161.58 | A$33.82 | -79% |
| BrightSpring Health Services, Inc BTSG | $60.59 | $23.87 | -61% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $86.03 | $54.47 | -37% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is TAKE Solutions Limited (TAKE) undervalued?
What is the fair value of TAKE?
What is the quality score of TAKE?
What is the revenue of TAKE Solutions Limited (TAKE)?
What is the net profit margin of TAKE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.